Chinese burn: new blacklists to expose healthcare company misbehaviour
This article was originally published in Scrip
Executive Summary
Pharmaceutical companies that value their reputation in China will soon need to tread more carefully when it comes to keeping in line with local drug and device laws. From 1 October a new blacklist will publically expose misbehaving companies and their misdemeanours for patients and healthcare professionals to see.